This review aims to systematically summarize the mechanistic insights and clinical advances of GLP-1with dual or triple receptor agonists in MASLD treatment, thereby promoting a more profound comprehension and facilitating their application in clinical practice (Figure 1)
A May 2024 survey from the International Foundation of Employee Benefit Plans found that 34% of employers covered GLP-1 drugs, up from 26% in 2023
In the future, we look forward to the clinical research evidence of small-molecule GLP-1RA intervening in ischemic stroke or T2D complicated by ischemic stroke
doi: 10.1007/s00253-023-12934-1 373 ZhangL.YangZ.YangF.WangG.ZengM.ZhangZ.et al
Think of it like gently folding ingredients into a delicate cake batter, not using an industrial mixer
8-epi prostaglandin F2 (8-epi PGF2) assay Brain 8-epi PGF2 content was determined with an 8-Isoprostane ELISA Kit (Cayman Chemicals, USA, Catalogue number: 516351)